4//SEC Filing
Singh Shawn 4
Accession 0001415889-21-003387
CIK 0001411685other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:10 PM ET
Size
5.6 KB
Accession
0001415889-21-003387
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2021-06-30$1.95/sh+5,000$9,733→ 45,375 total
Holdings
- 26,234(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001412071
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:10 PM ET
- Size
- 5.6 KB